Correct Answer: B. Acoustic neuromas
Acoustic neuromas (vestibular schwannomas) are the hallmark feature of neurofibromatosis type 2 (NF2), not NF1. The NIH diagnostic criteria for NF1 require two or more of the following: café-au-lait spots (≥6, diameter >5 mm), neurofibromas (≥2 cutaneous or ≥1 plexiform), freckling in axillary or inguinal regions, optic nerve glioma, Lisch nodules (iris hamartomas, ≥2), distinctive osseous lesions (sphenoid dysplasia, tibial pseudarthrosis), or a first-degree relative with NF1. Acoustic neuromas are bilateral in ~90% of NF2 patients and are rare in NF1. This distinction is critical in Indian pediatric practice where NF1 is more common (1 in 2,500–3,000 births) than NF2 (1 in 25,000). Confusing NF1 with NF2 is a common examination trap. The question specifically asks what is not included in NF1 criteria, making acoustic neuromas the correct answer—they belong exclusively to NF2's diagnostic framework.
Why the other options are wrong
A. Dysplasia of the sphenoidal and tibial bone — This is a cardinal osseous manifestation of NF1 included in NIH criteria. Sphenoid wing dysplasia causes facial asymmetry and proptosis; tibial pseudarthrosis leads to pathological fractures and limb deformity. Both are well-recognized skeletal complications in Indian NF1 cohorts and are explicitly listed as major diagnostic criteria. C. Cafe-au-lait spots — Café-au-lait spots (≥6 lesions, each >5 mm diameter) are the most common and earliest clinical sign of NF1, present in >99% of patients by age 8 years. They are a mandatory screening feature in Indian pediatric clinics and form part of the NIH diagnostic criteria. This option is definitively included in NF1. D. Two or more iris hamartomas — Lisch nodules (iris hamartomas, ≥2) are present in ~90% of NF1 patients by age 6 years and are a major NIH diagnostic criterion. They are asymptomatic, detected on slit-lamp examination, and serve as a sensitive marker for NF1 in Indian pediatric screening protocols. This option is clearly included in NF1 criteria.
High-Yield Facts
- NF1 vs NF2: Acoustic neuromas (bilateral vestibular schwannomas) are pathognomonic for NF2, NOT NF1—this is the key discriminator in this question.
- NIH NF1 Diagnostic Criteria: Require ≥2 of 7 features including café-au-lait spots (≥6, >5 mm), neurofibromas, Lisch nodules (≥2), optic nerve glioma, sphenoid/tibial dysplasia, axillary/inguinal freckling, or affected first-degree relative.
- Café-au-lait spots: Present in >99% of NF1 by age 8; are the earliest and most common sign; ≥6 spots >5 mm diameter is diagnostic threshold.
- Lisch nodules: Iris hamartomas present in ~90% of NF1 by age 6; asymptomatic; detected on slit-lamp; highly specific for NF1.
- Osseous manifestations of NF1: Sphenoid wing dysplasia (facial asymmetry, proptosis) and tibial pseudarthrosis (pathological fractures) are major skeletal complications included in diagnostic criteria.
- NF1 prevalence in India: 1 in 2,500–3,000 births; NF2 is much rarer (1 in 25,000); NF1 accounts for >90% of neurofibromatosis cases in Indian pediatric populations.
Mnemonics
NF1 vs NF2 — 'ACOUSTIC = NF2' Remember: Acoustic neuromas = NF2. If you see bilateral vestibular schwannomas or acoustic neuromas, think NF2, not NF1. NF1 has café-au-lait spots, Lisch nodules, and bone dysplasia—not acoustic neuromas. NIH NF1 Criteria — 'FLONC' Freckling (axillary/inguinal), Lisch nodules (≥2), Optic nerve glioma, Neurofibromas (≥2 cutaneous or ≥1 plexiform), Café-au-lait spots (≥6, >5 mm). Plus osseous lesions and family history. Need ≥2 features.
NBE Trap
NBE pairs "acoustic neuromas" with neurofibromatosis to trap students who conflate NF1 and NF2. The question's phrasing ("not included") requires careful reading—students rushing may select café-au-lait spots or Lisch nodules (which ARE in NF1) instead of recognizing that acoustic neuromas belong exclusively to NF2.
Clinical Pearl
In Indian pediatric practice, NF1 screening begins with counting café-au-lait spots and performing slit-lamp examination for Lisch nodules by age 6. If a child presents with bilateral acoustic neuromas or progressive hearing loss, suspect NF2 instead—a distinct entity requiring different surveillance (MRI spine, skin biopsies for schwannomas) and genetic counseling. This distinction changes management and prognosis significantly.
_Reference: OP Ghai Essentials of Pediatrics (NF1 diagnostic criteria); Harrison Ch. 375 (Neurofibromatosis); Robbins Ch. 7 (Genetic Disorders)_